During 2023, Inke has increased its production capacity by making a significant investment in new reactors and clean rooms. This initiative has been carried out with the support of ACCIÓ from the Generalitat de Catalunya.
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs